Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (71)

« Back to Publications

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Thadhani R. et al, (2026), Nat Med

cute Presentation of Nonpuerperal Uterine Inversion Following a Diagnosis of Uterine Carcinosarcoma: A Case Report

More AK. et al, (2026), Clinical Case Reports, 14

Considerations for gestational age, delivery indication, and therapies in preeclampsia prediction.

Palma Dos Reis CR. et al, (2025), Am J Obstet Gynecol, 233

Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan.

Yamazaki T. et al, (2025), Hypertens Res, 48, 2548 - 2557

The ratio of soluble fms-like tyrosine kinase 1 to placental growth factor predicts time to delivery and mode of birth in patients with suspected preeclampsia: a secondary analysis of the INSPIRE trial.

Palma Dos Reis CR. et al, (2025), Am J Obstet Gynecol, 232, 317.e1 - 317.e17

FGFR2 Genetic Variant C.1019A > G p.(Tyr340Cys) in a Fetus with Pfeiffer Type II Syndrome Diagnosed by a Combination of 3D Ultrasound Phenotyping and DNA Sequencing

Scalia MS. et al, (2025), Journal of Fetal Medicine, 12, 032 - 034

Soluble fms-like tyrosine kinase 1-to-placental growth factor ratio predicts time to delivery and mode of birth.

Palma Dos Reis CR. et al, (2025), Am J Obstet Gynecol, 232

hsa-miR-9-5p highly expressed in syncytiotrophoblast-derived extracellular vesicles from early-onset preeclampsia impairs cerebral microvascular endothelial cell pro-angiogenic capacity

Logenthiran P. et al, (2024)

Cerebroplacental ratio in low-risk pregnancies: the RATIO37 trial.

Bacon I. et al, (2024), Lancet, 404, 750 - 751

Syncytiotrophoblast extracellular vesicles contain functional kynurenine metabolising enzymes: potential implications for preeclampsia

Logenthiran P. et al, (2024)

Serial placental growth factor-based testing in pre-eclampsia.

Cerdeira AS. and Karumanchi SA., (2024), Lancet, 403, 588 - 589

Translation of mechanistic advances in preeclampsia to the clinic: Long and winding road.

Thadhani R. et al, (2024), FASEB J, 38

MicroRNA analysis of medium/large placenta extracellular vesicles in normal and preeclampsia pregnancies.

Awoyemi T. et al, (2024), Front Cardiovasc Med, 11

The sFlt1/PlGF ratio predicts faster fetal deterioration in early fetal growth restriction: A historical cohort study.

Palma Dos Reis CR. et al, (2023), Acta Obstet Gynecol Scand, 102, 635 - 643

Novel therapeutic and diagnostic approaches for preeclampsia.

Vatish M. et al, (2023), Curr Opin Nephrol Hypertens, 32, 124 - 133

Load More

1
2
3
4
5